Table of Content

1. Executive Summary


2. Introduction

2.1 Pharmaceutical Industry Overview
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
2.1.2 Small Molecule vs Biological Drugs

2.2 Drug Manufacturing Process
2.2.1 Drug Manufacturing Process
2.2.2 Comparison: In-House Vs CMO Production


3. Global Market Analysis

3.1 Global Pharmaceutical Market Analysis

3.1.1 Global Pharmaceutical Market by Value
3.1.2 Global Pharmaceutical Market by Molecule-Type
3.1.3 Global Small Molecule Market by Value

3.2 Global Pharmaceutical Manufacturing Market Analysis

3.2.1 Global Pharmaceutical Manufacturing Market by Value
3.2.2 Global Pharmaceutical Manufacturing Market by Production

3.3 Global Small Molecule CMO Market Analysis

3.3.1 Global Outsourced/CMO Market by Value
3.3.2 Global Outsourced/CMO Market by Molecule-Type
3.3.3 Global Small Molecule CMO Market by Value
3.3.4 Global Small Molecule CMO Market by Segments (Originator Drugs, Generic Drugs)
3.3.5 Global Small Molecule CMO Market by Region

3.4 Global Small Molecule CMO Market: Segment Analysis

3.4.1 Global Small Molecule CMO Generic Drug Market by Value
3.4.2 Global Small Molecule CMO Originator Drug Market by Value


4. Regional Analysis

4.1 The U.S. Small Molecule CMO Market Analysis
4.1.1 The U.S. Small Molecule CMO Market by Value

4.2 China Small Molecule CMO Market Analysis
4.2.1 China Small Molecule CMO Market by Value


5. Market Dynamics

5.1 Growth Drivers
5.1.1 Global Pharmaceutical Industry Growth
5.1.2 Growing Demand for Oncology Drugs
5.1.3 Growing Demand for Process Development CMO Services
5.1.4 Low Manufacturing Cost
5.1.5 Robust Pipeline of Small Molecule Drugs and Increasing Rate of FDA Approvals

5.2 Challenges
5.2.1 Risk Associated with CMOs
5.2.2 Stringent Regulations
5.2.3 Technical Challenges
5.2.4 Intellectual Property Risks and Quality Issues

5.3 Market Trends
5.3.1 Entrance of Numerous Small, Virtual Startups
5.3.2 Increasing Complexity of Small Molecule Drugs
5.3.3 Mergers & Acquisitions
5.3.4 Growing Demand for CDMOs Offering Highly Potent API
5.3.5 Capacity Utilization Rate of CMO Industry


6. Competitive Landscape

6.1 Global Small Molecule CMO Market by Players


7. Company Profiles

7.1 Lonza Group
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 Wuxi AppTec Co., Ltd
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 Catalent, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

7.4 Patheon Inc.
7.4.1 Business Overview
7.4.2 Business Strategy
 



List of Figures



Figure 1: History of Pharmaceutical Industry
Figure 2: Pharmaceutical Industry Segments
Figure 3: Drug Manufacturing Process
Figure 4: Global Pharmaceutical Market by Value; 2014-2018 (US$ Trillion)
Figure 5: Global Pharmaceutical Market by Value; 2019-2023E (US$ Trillion)
Figure 6: Global Pharmaceutical Market by Molecule-Type; 2018
Figure 7: Global Small Molecule Market by Value; 2017-2018 (US$ Billion)
Figure 8: Global Small Molecule Market by Value; 2019-2023E (US$ Billion)
Figure 9: Global Pharmaceutical Manufacturing Market by Value; 2017-2018 (US$ Billion)
Figure 10: Global Pharmaceutical Manufacturing Market by Value; 2019-2023E (US$ Billion)
Figure 11: Global Pharmaceutical Drug Manufacturing Market by Production; 2018
Figure 12: Global Outsourced/CMO Market by Value; 2017-2018 (US$ Billion)
Figure 13: Global Outsourced/CMO Market by Value; 2019-2023E (US$ Billion)
Figure 14: Global Outsourced/CMO Market by Molecule-Type; 2018
Figure 15: Global Small Molecule CMO Market by Value; 2017-2018 (US$ Billion)
Figure 16: Global Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 17: Global Small Molecule CMO Market by Segments; 2018
Figure 18: Global Small Molecule CMO Market by Region; 2018
Figure 19: Global Small Molecule CMO Generic Drug Market by Value; 2017-2018 (US$ Billion)
Figure 20: Global Small Molecule CMO Generic Drug Market by Value; 2019-2023E (US$ Billion)
Figure 21: Global Small Molecule CMO Originator Drug Market by Value; 2017-2018 (US$ Billion)
Figure 22: Global Small Molecule CMO Originator Drug Market by Value; 2019-2023E (US$ Billion)
Figure 23: The U.S. Small Molecule CMO Market by Value; 2014-2018 (US$ Billion)
Figure 24: The U.S. Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 25: China Small Molecule CMO Market by Value; 2014-2018 (US$ Billion)
Figure 26: China Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 27: Global Pharmaceutical Industry by Value; 2016-2023 (US$ Trillion)
Figure 28: Global Oncology Drugs Market; 2017-2023 (US$ Billion) 2010-2017
Figure 29: Capacity Utilization Rate of the Global CMO Industry; 2014-2020 (%)
Figure 30: Global Small Molecule CMO Market by Players; 2018
Figure 31: Lonza Group Sales; 2014-2018 (US$ Billion)
Figure 32: Lonza Group Sales by Segments; 2018
Figure 33: Wuxi AppTec Co., Ltd & CMO Services Revenue; 2015-2017 (US$ Million)
Figure 34: Wuxi AppTec Co., Ltd Revenue by Segments; 2017
Figure 35: Catalent, Inc. Revenue; 2014-2018 (US$ Billion)
Figure 36: Catalent, Inc. Revenue by Segments; 2018
Table 1: Characteristics of Small Molecule Drugs Compared to Biologicals
Table 2: Comparison: In-House Vs CMO Production
Table 3: Small Molecule and Biologics New Molecular Entities Approved by FDA, 2010-2017